Ensysce Biosciences Inc (ENSC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $8.14M
Last updated: Nov 17, 2026 at 11:03 AM ET
Ensysce Biosciences Inc (ENSC) Stock Forecast
Analysts expect Ensysce Biosciences (ENSC) to earn -$0.23 per share in the fiscal year ending Dec 31, 2026, on revenue of $4.67M. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.05.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates fall 21.4%.
- Fiscal year ending Dec 31, 2026
- -$0.23
- EPS consensus, revenue $4.67M
- Fiscal year ending Dec 31, 2027
- -$0.05
- EPS consensus, revenue $3.67M
- Next report
- Mar 29, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.23 | -$0.23 to -$0.23 | 1 | $4.67M | $4.40M to $5.02M | 3 |
| Dec 31, 2027 | -$0.05 | -$0.06 to -$0.05 | 2 | $3.67M | $3.00M to $4.34M | 2 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.08 | -$0.14 to -$0.01 | 4 | $900997 | N/A | 5 |
Estimate Revisions
No EPS estimate for the 2 periods below was revised in the last 30 days.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 0 |
EPS Trend
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2027 | -$0.05 | -$0.05 | -$0.05 | -$0.05 | -$0.05 | N/A |
Frequently Asked Questions About ENSC
What is the ENSC stock forecast?
Consensus analyst estimates put Ensysce Biosciences's EPS at -$0.23 for the fiscal year ending Dec 31, 2026, on revenue of $4.67M.
What EPS do analysts expect from ENSC next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.23, with estimates from -$0.23 to -$0.23 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.05, with estimates from -$0.06 to -$0.05 from 2 analysts.
What revenue do analysts expect from Ensysce Biosciences next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $4.67M, with estimates from $4.40M to $5.02M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $3.67M, with estimates from $3.00M to $4.34M.
How many analysts cover ENSC?
1 analyst estimates EPS for Ensysce Biosciences for the fiscal year ending Dec 31, 2026.
ENSC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors